improving specificity of psa screening w/ serum & urine markers: who doesn’t need a prostate biopsy?
Published 3 years ago • 1.4K plays • Length 16:56Download video MP4
Download video MP3
Similar videos
-
11:54
screening and prevention of prostate cancer 2021 - who needs a biopsy?
-
6:43
in my opinion: biomarkers for the diagnosis of prostate cancer
-
48:12
considerations to improve screening for prostate cancer
-
12:07
screening and prevention of prostate cancer 2021 (part 1) - evidence for psa screening
-
9:18
screening for prostate cancer: psa: why 1.5 is the new 4
-
16:25
forward progress in molecular markers in prostate cancer
-
7:08
updates in screening: prostate cancer guidelines
-
17:40
when to biopsy: the role for psa and novel biomarkers
-
21:38
tumor markers and prostate cancer screening
-
18:30
prostate cancer early diagnosis screening
-
30:52
webinar emerging evidence on psa in the diagnosis of prostate cancer
-
14:05
integrating mri and molecular markers to detect aggressive prostate cancer
-
21:38
tumor markers and prostate cancer screening
-
29:23
how should we monitor patients during surveillance?
-
10:37
liquid diagnostics and prostate cancer
-
6:18
updates of changes in the early detection of prostate cancer nccn guidelines 2021
-
16:36
early diagnosis of prostate cancer: a path forward
-
45:27
5.27.2020 urology covid didactics - active surveillance for early stage prostate cancer
-
6:52
prostate-specific antigen (psa) tests for prostate cancer